VTRS Stock Analysis: Buy, Sell, or Hold?
VTRS - Viatris Inc. Common Stock
Smart Money Distribution
VTRS is up 3.2% this week, but smart money is buying puts. Top strike: $13 2026-05-15 with 370 OI. Put ratio: 99% View Scanner →
Get Alerted When VTRS Hits Your Target Price
Join 10,000+ traders who never miss a move
Interactive Price Chart (1 Month)
Loading historical data...
💡 BUY OPPORTUNITY: VTRS shows positive signals but monitor for confirmation. Market pricing in 0.4% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 5.2x Exit PE.
In-depth Analysis How we analyze
Technical Outlook: Technically, VTRS is in a strong uptrend. The price is approaching resistance at $13.79. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: VTRS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $15.72 (+13.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
All Signals
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($15.72)
Fair Price Analysis
Support & Resistance Levels
Fundamental Context
Data refreshes hourly during market hours. Next update: 8:32 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Is VTRS showing a specific setup today?
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$185 | 60 HOLD |
|
ZTS
Zoetis Inc |
STRONG BUY
19 analysts |
$151 | 60 BUY |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$91 | 57 HOLD |
|
HCM
HUTCHMED DRC |
STRONG BUY
14 analysts |
$23 | 63 BUY |
|
AQST
Aquestive Therapeutics I… |
STRONG BUY
9 analysts |
$9 | 64 BUY |
Advanced VTRS Option Strategies
Professional options setups generated by AI based on today's VTRS price and gamma walls.